In a 50-year-old woman taking sertraline 100 mg who is experiencing vasomotor (hot‑flash) symptoms, what is an appropriate add‑on therapy?

Add Gabapentin or Venlafaxine for Vasomotor Symptoms

Since this patient is already on sertraline 100 mg (an SSRI), the best add-on therapy is gabapentin 300 mg at bedtime, titrating up to 900-2400 mg/day as tolerated, or alternatively switching to venlafaxine 75-150 mg/day if the sertraline is not essential for mood.

Why Not Continue Sertraline Alone?

Sertraline specifically has been shown to be ineffective for vasomotor symptoms. A high-quality RCT demonstrated that sertraline 100 mg produced no better reduction in hot flash frequency (39% vs 38% placebo) or severity compared to placebo, while causing more gastrointestinal complaints, dry mouth, and dizziness 1. This makes continuing sertraline alone without additional therapy inappropriate for this indication.

First-Line Add-On: Gabapentin

Gabapentin is the optimal add-on choice because:

• Dosing strategy: Start 300 mg at bedtime (sedative effects dissipate by morning), then escalate to 300 mg three times daily, with effective range 900-2400 mg/day 2
• Efficacy: Reduces hot flash frequency and composite scores by approximately 60-70% 2
• Tolerability: Side effects (fatigue, dizziness, peripheral edema) are manageable when titrated appropriately 3
• No drug interaction: Gabapentin does not interact with sertraline, allowing continuation of SSRI therapy if needed for mood

The sedative properties of gabapentin actually work synergistically with its vasomotor effects when dosed at bedtime, addressing both hot flashes and sleep disruption common in menopause 2.

Alternative: Switch to Venlafaxine

If sertraline is not critical for treating depression or anxiety, consider switching to venlafaxine 75-150 mg/day rather than adding therapy:

• Superior efficacy: Venlafaxine (SNRI) reduces hot flash scores by approximately 66% 2
• Patient preference: Two-thirds of patients prefer venlafaxine over gabapentin in head-to-head trials 2
• Better tolerated: Compared to gabapentin, venlafaxine has fewer sedating effects during daytime hours 4

Second-Line Option: Pregabalin

If gabapentin is not tolerated, pregabalin 75-150 mg twice daily is an alternative, reducing hot flash scores by 65-71% 2. However, it may impair memory and concentration more than gabapentin.

Avoid Clonidine as Add-On

Clonidine is less effective than SSRIs/SNRIs, gabapentin, and pregabalin, with more side effects (hypotension, dry mouth, fatigue, constipation) 2, 3. Reserve this only if the patient fails or cannot tolerate first-line options 2.

Critical Caveat: Hormone Therapy Consideration

While not an "add-on" to sertraline, standard-dose menopausal hormone therapy (MHT) remains more effective than all nonhormonal agents for vasomotor symptoms, reducing frequency by approximately 75% 2, 5. If this 50-year-old woman has no contraindications (recent breast cancer, active cardiovascular disease, history of venous thromboembolism), she should be counseled about MHT as the most effective option, particularly since she is likely within 10 years of menopause onset when the benefit-risk profile is most favorable 3.

The absolute increased risk with conjugated equine estrogens is approximately 1 excess cardiovascular or breast cancer event per 1000 person-years 5, which may be acceptable for severe symptoms significantly impacting quality of life.

Practical Algorithm

1. Assess if sertraline is necessary for psychiatric indication

   • If NO → Switch to venlafaxine 75-150 mg/day
   • If YES → Add gabapentin 300 mg at bedtime, titrate to 900-2400 mg/day

2. If gabapentin fails or not tolerated → Try pregabalin 75-150 mg twice daily

3. If all nonhormonal options fail → Reassess MHT candidacy (estradiol ± progestogen if uterus intact)

4. Reserve clonidine only after failure of above options